Logo

UBS Upgrades Bruker BioSciences After Firm Announces Plan to Buy Bruker Optics

Apr 20, 2006

NEW YORK, April 20 (GenomeWeb News) - UBS today upgraded its assessment of Bruker BioSciences to "Buy" from "Neutral," two days after Bruker announced plans to purchase privately held Bruker Optics.

As GenomeWeb News reported on Tuesday, Bruker said it plans to pay $135 million for Bruker Optics, which makes molecular spectroscopy platforms, the companies said this week.

The acquisition will enable Bruker BioSciences to sell mass spectrometry, X-ray-analysis, and now molecular spectroscopy platforms for proteomics as well as chemical and materials analysis, Bruker said.

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.